Drug intelligence / Profile preview

1-androstenedione

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

1-Androstenedione is a synthetic anabolic steroid and a metabolite of 1-testosterone. It acts as a prohormone, being converted in the body to more active androgens such as testosterone. Like other anabolic steroids, it is used with the intent to increase muscle mass, strength, and athletic performance. However, its efficacy for these purposes has not been conclusively demonstrated in scientific studies. In the United States, 1-androstenedione is regulated as a Schedule III controlled substance due to its potential for abuse and health risks associated with anabolic steroids[1]. It is primarily intended for research and forensic applications rather than medical use.

Other names: 1-androstenedione

Targets

AR (Adrenergic receptors)ER (Estrogen receptor)

Beyond the preview

Go deeper on 1-androstenedione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-androstenedione.

Explore the full profile